[Hepatoblastoma in an infant after Estroprogestational intake by the mother during pregnancy].
The clinical course of a case of hepatoblastoma in an infant following the use of an oral contraceptive during the Ist month of pregnancy is reviewed. The following points are worthy of considerations: age of onset, clinical silence, rapid terminal course, AFP negativity.
D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000473:pathology; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008431:Maternal-Fetal Exchange; D009644:Norgestrel / Q000009:adverse effects*; D011247:Pregnancy
D009644:Norgestrel; D004997:Ethinyl Estradiol
Epatoblastoma in lattante dopo assunzione di estroprogestinici da parte della madre in gravidanza.